Your browser doesn't support javascript.
loading
Differential Effects of HLA-B∗15:11 and HLA-A∗31:01 on Carbamazepine-Induced Cutaneous Adverse Reactions.
Fukunaga, Koya; Tsukagoshi, Eri; Kurata, Maiko; Mizukawa, Yoshiko; Niihara, Hiroyuki; Morita, Eishin; Watanabe, Yuko; Yamaguchi, Yukie; Watanabe, Hideaki; Nakajima, Saeko; Nomura, Takashi; Kabashima, Kenji; Tohyama, Mikiko; Azukizawa, Hiroaki; Asada, Hideo; Hasegawa, Akito; Hama, Natsumi; Ozeki, Takeshi; Mashimo, Yoichi; Sekine, Akihiro; Matsunaga, Kayoko; Tanaka, Yoichi; Nakamura, Ryosuke; Abe, Riichiro; Mushiroda, Taisei; Saito, Yoshiro.
Afiliación
  • Fukunaga K; Laboratory for Pharmacogenomics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan; Division of Medicinal Safety Science, National Institute of Health Sciences, Kawasaki, Japan.
  • Tsukagoshi E; Division of Medicinal Safety Science, National Institute of Health Sciences, Kawasaki, Japan.
  • Kurata M; Department of Dermatology, Kyorin University School of Medicine, Tokyo, Japan.
  • Mizukawa Y; Department of Dermatology, Kyorin University School of Medicine, Tokyo, Japan.
  • Niihara H; Department of Dermatology, Faculty of Medicine, Shimane University, Shimane, Japan.
  • Morita E; Department of Dermatology, Faculty of Medicine, Shimane University, Shimane, Japan.
  • Watanabe Y; Department of Environmental Immuno-Dermatology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Yamaguchi Y; Department of Environmental Immuno-Dermatology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Watanabe H; Department of Dermatology, Showa University Northern Yokohama Hospital, Yokohama, Japan.
  • Nakajima S; Department of Dermatology, Graduate School of Medicine and Faculty of Medicine, Kyoto University, Kyoto, Japan.
  • Nomura T; Department of Dermatology, Graduate School of Medicine and Faculty of Medicine, Kyoto University, Kyoto, Japan.
  • Kabashima K; Department of Dermatology, Graduate School of Medicine and Faculty of Medicine, Kyoto University, Kyoto, Japan.
  • Tohyama M; Department of Dermatology, National Hospital Organization Shikoku Cancer Center, Japan.
  • Azukizawa H; Department of Dermatology, School of Medicine, Nara Medical University, Kashihara, Japan.
  • Asada H; Department of Dermatology, School of Medicine, Nara Medical University, Kashihara, Japan.
  • Hasegawa A; Division of Dermatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
  • Hama N; Division of Dermatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
  • Ozeki T; Laboratory for Pharmacogenomics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
  • Mashimo Y; Department of Public Health, Chiba University Graduate School of Medicine, Chiba, Japan.
  • Sekine A; Department of Public Health, Chiba University Graduate School of Medicine, Chiba, Japan.
  • Matsunaga K; Department of Integrative Medical Science for Allergic Disease, Fujita Health University School of Medicine, Nagoya, Japan.
  • Tanaka Y; Division of Medicinal Safety Science, National Institute of Health Sciences, Kawasaki, Japan.
  • Nakamura R; Division of Medicinal Safety Science, National Institute of Health Sciences, Kawasaki, Japan.
  • Abe R; Division of Dermatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
  • Mushiroda T; Laboratory for Pharmacogenomics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan. Electronic address: mushiroda@riken.jp.
  • Saito Y; Division of Medicinal Safety Science, National Institute of Health Sciences, Kawasaki, Japan.
J Invest Dermatol ; 144(4): 908-911.e7, 2024 Apr.
Article en En | MEDLINE | ID: mdl-37914023

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Síndrome de Stevens-Johnson / Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos Límite: Humans Idioma: En Revista: J Invest Dermatol Año: 2024 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Síndrome de Stevens-Johnson / Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos Límite: Humans Idioma: En Revista: J Invest Dermatol Año: 2024 Tipo del documento: Article País de afiliación: Japón